GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%
Mon, 3 Jun

GLENMARK PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

GLENMARK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m22,79825,55025,6350.3%12.4%
Other incomeRs m696-1,090391-43.8%
TurnoverRs m23,49424,46026,0256.4%10.8%
ExpensesRs m19,53021,20421,9933.7%12.6%
Gross profitRs m3,2684,3473,641-16.2%11.4%
DepreciationRs m735831810-2.6%10.1%
InterestRs m744885819-7.5%10.1%
Profit before taxRs m2,4851,5402,40356.0%-3.3%
TaxRs m968377786108.7%-18.8%
Profit after taxRs m1,5161,1631,61739.0%6.6%
Gross profit margin%14.317.014.2
Effective tax rate%39.024.532.7
Net profit margin%6.54.86.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 12.4% on a year-on-year (YoY) basis. The expenses were up by 12.6% YoY during the same period.
  • The company's operating profit increased by 11.4% YoY during the quarter. Consequently, operating profit margins remained same and stood at 14.2% in 4QFY19.
  • Depreciation charges increased by 10.1% and finance costs increased by 10.1% YoY, respectively.
  • Other income declined by 43.8% YoY during the quarter.
  • Net profit for the quarter increased by 6.6% YoY. Net profit margins during the quarter declined from 6.5% in 4QFY18 to 6.2% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.7% QoQ during the same period.
  • The company's operating profit declined by 16.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.2% in 4QFY19 as against 17.0% in 3QFY18.
  • Net profit for the quarter increased by 39.0% QoQ, while net profit margins increased from 4.8% in 3QFY18 to 6.2% in 4QFY19.

To see how GLENMARK PHARMA has performed over the last eight quarters, please visit here.

GLENMARK PHARMA Share Price Performance

Over the last one year, GLENMARK PHARMA share price has moved up from Rs 535.2 to Rs 542.9, registering a Gain of Rs 7.7 or around 1.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,339.5 (up 0.3%). Over the last one year it has moved up from 12,945.5 to 13,339.5, a gain of 394 points (up 3.0%).

Overall, the S&P BSE SENSEX is up 13.2% over the year.

Current Valuations

At the current price of Rs 542.9, the price to earnings (P/E) ratio of GLENMARK PHARMA stands at 15.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.9 times.

Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%". Click here!

1 Responses to "GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%"

Kritarthajeet Sengupto

Jun 25, 2019

This scrip is consistently going down. What is your advice to investors.

Like (1)
  
Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%". Click here!

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


May 18, 2021 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 8-QTR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS